Pharma companies' strategies for reaching poorer countries remain unclear

SciDev.NetSep 12 2024 Pharmaceutical companies must prioritize efforts to reach patients in underserved parts of the world with medicines such as insulin for diabetics and, crucially, measure the effectiveness of these efforts, says Jayasree Iyer, CEO of the Access to Medicine Foundation.

Iyer says companies first need to know how many treatment-eligible patients there are in each of their markets. “You need to know the burden of a disease, so that you know how many people you’re going to be reaching – and then reach them with your efforts,” she says. Out of 42 patient-reach approaches that the companies spelt out, 13 don’t include any goals. More than a third of the existing goals aren’t clear and measurable, says the report.

But that’s not true of all countries, she says. And from the perspective of local communities, this can feel like companies are not making the effort.

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

For pharma, Trump vs. Harris is a showdown between two industry foesFormer President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and divisive contest: It's up to the government to cut high U.S. drug prices.
ソース: medical_xpress - 🏆 101. / 51 続きを読む »